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In recent years, there has been growing awareness of the significant burden of Chagas dis-
ease in the United States (US). However, epidemiological data on both prevalence and
access to care for this disease are limited. The objective of this study is to provide an
updated national estimate of Chagas disease prevalence, the first state-level estimates of
cases of T. cruzi infection in the US and to analyze these estimates in the context of data on
confirmed cases of infection in the US blood supply.
Methods
In this study, we calculated estimates of the state and national prevalence of Chagas dis-
ease. The number of residents originally from Chagas disease endemic countries were
computed using data on Foreign-Born Hispanic populations from the American Community
Survey, along with recent prevalence estimates for Chagas disease in Latin America from
the World Health Organization that were published in 2006 and updated in 2015. We then
describe the distribution of estimated cases in each state in relation to the number of infec-
tions identified in the donated blood supply per data from the AABB (formerly American
Association of Blood Banks).
Findings
The results of this analysis offer an updated national estimate of 238,091 cases of T. cruzi
infection in the United States as of 2012, using the same method as was used by Bern and
Montgomery to estimate cases in 2005. This estimate indicates that there are 62,070 cases
less than the most recent prior estimate, though it does not include undocumented immi-
grants who may account for as many as 109,000 additional cases. The state level results
show that four states (California, Texas, Florida and New York) have over 10,000 cases
and an additional seven states have over 5,000 cases. Moreover, since 2007, the AABB
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has reported 1,908 confirmed cases of T. cruzi infection identified through screening of
blood donations.
Conclusions
This study demonstrates a substantial burden of Chagas disease in the US, with state vari-
ation that reflects the distribution of at risk Latin American immigrant populations. The
study lends important new insight into the distribution of this disease in the US and high-
lights the need for further research quantifying prevalence and incidence to guide interven-
tions for control of Chagas disease across the US.
Author Summary
Chagas disease is a parasitic infection that primarily affects poor populations in Latin
America. However, awareness of this disease in the United States has increased in recent
years. In this study, we utilize data from the American Community Survey and theWorld
Health Organization to estimate the number of cases of Chagas disease in the United
States. We find that there are an estimated 238,000 cases across the United States, along
with four states that each has over 10,000 cases (California, Texas, New York and Florida).
We also analyze data from the United States blood donation which shows that about 1,900
cases have been identified through blood donation. We conclude that there is still a sub-
stantial burden of Chagas disease in the US, though the burden is focused in certain geo-
graphic regions.We also highlight the need for further research to better quantify
prevalence and incidence in order to guide interventions to diagnose and treat patients
with Chagas disease across the US.
Introduction
Chagas disease, caused by infectionwith the parasite Trypanosoma cruzi, affects an estimated
8–10 million people globally. Among those infected with the parasite, approximately 30% will
develop chronic Chagas cardiac disease, including serious arrhythmias and heart failure. This
infection can also be transmitted congenitally, from infectedmother to child. Though Chagas
disease has historically been considered a condition of the rural poor in Latin America, in
recent years there has been growing recognition of the burden of Chagas disease in the United
States (US) and Europe due to human migration from Latin America.[1–3]Moreover, both
autochthonous transmission in the southern US and congenital transmission have been docu-
mented, although the numbers of cases are small and the risk of transmission is undefined.[4,
5] In the United States, there is no national level surveillance for Chagas disease; the most
recent study to estimate the prevalence of this disease in the US, published in 2009, concluded
that approximately 300,167 individuals with Chagas disease were living in the United States in
2005.[1]
Since these estimates were published, a more recent American Community Survey (ACS)
was released, allowing for an updated estimation of the numbers of T. cruzi infections at both
the state and national level. In addition, screening of the blood supply was initiated in 2007 and
surveillancedata on cases identified in the donated blood supply since that time offer addi-
tional insight into the geographic distribution of Chagas disease in the US. The objective of this
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study is to provide an updated national estimate and the first state-level estimates of cases of T.
cruzi infection in the US as of 2012–2013 and to analyze these estimates in the context of data
on confirmed cases of infection in the US blood supply during the period from 2007–2013.
Methods
In this study, we calculated estimates of the state and national prevalence of Chagas disease.
We did not estimate possible US-acquired infections, either congenital or vector-borne. State-
level estimates of the number of residents originally from Chagas disease endemic countries
were computed using data on Foreign-BornHispanic populations by state from the ACS; state
totals were summed to provide a national estimate. This was compared to the national level
estimate generated using data on Foreign-BornHispanic populations for the entire nation
from the ACS. To estimate the number of cases of Chagas disease we used recent prevalence
estimates for the Latin American countries of origin from theWorld Health Organization
(WHO).[6–8] TheWHO has provided country-basedestimates of prevalence of T. cruzi infec-
tion in 2006 and updated these estimates in 2015 to reflect the impact of national vector control
programs in the intervening period. State-Level Foreign-BornHispanic Population Estimates
by single Country of Origin group were computed using the 2012 ACS data for a five-year
period (2008–2012).
The prevalence by state was estimated using Hispanic Country of Origin groups for each
state as estimated by the ACS. For each single Country of Origin group, an expected number of
cases were computed by multiplying the estimated state population by the proportion who had
migrated prior to 2010 by the respective prevalence in 2006 in the Country of Origin and add-
ing to that the estimated population that had migrated after 2010 multiplied by the respective
prevalence reported by WHO in 2015. This method is represented in the following equation:
Estimated Cases of Chagas disease in State B from Country A Origin Group = (Population
that migrated from Country A to State B prior to 2010XNational prevalence of T. cruzi infection
in Country B per WHO 2006) + (Population that migrated from Country A to State B after 2010
X National prevalence of T. cruzi infection in Country B per WHO 2015)
The estimated number of cases for each state was calculated as the sum of the expected
number of cases for each of the single Hispanic Country of Origin groups in that state. The
state totals were then added to provide a national prevalence estimate. For comparability, we
also calculated the estimated number of cases at the national level in 2012 by taking the sum of
the estimated number of infections for each single Country of Origin group at the national
level. This method is the same as that which was used in Bern and Montgomery (see Table 1).
[1]
Finally, we describe the distribution of estimated cases in each state in relation to the num-
ber of infections identified in the donated blood supply per de-identified data from the AABB
(formerly American Association of Blood Banks). AABB aggregates voluntary reports of donor
Chagas disease testing frommost but not all U.S. blood collection agencies. These data include
all confirmed cases reported to them from January 2007 to September 2013. These data do not
include cases diagnosed via mechanisms other than blood donation, such as community-based
screening efforts or other clinical settings. [9] This study was approved by the Boston Univer-
sity Medical Center Institutional ReviewBoard (IRB) (Protocol H-32356).
Results
The results of this analysis offer an updated national estimate of 238,091 cases of T. cruzi infec-
tion in the United States as of 2012 using the same method as was used by Bern and Montgom-
ery to estimate the number of cases in 2005 (Table 1). [1] This represents a decrease of 62,070
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cases from this most recent prior estimate. By comparison, summing the number of cases esti-
mated by state offers a slightly lower national estimate of 238,072 cases. The state level results
show four states with over 10,000 cases and an additional seven states with over 5,000 cases
(Fig 1). Moreover, since 2007, the AABB has reported 1,908 confirmed cases of T. cruzi infec-
tion identified through screening of blood donations.
Discussion
This study offers the first state-level analysis of the burden of Chagas disease in the US and pro-
vides objective data to inform future policies on screening and clinical care provision for this
disease. This updated national estimate of 238,091 cases of T. cruzi infection represents an
approximately 20% decrease in the number of infections estimated for the US in 2005, most
likely due to a decrease in the estimated population of foreign-born Latin Americans based on
US Census population surveys conducted after 2005. The state level estimates show a geo-
graphically focal burden with highest estimated numbers of cases in California, Texas, Florida
and New York. Data on cases identified through blood donor screening is largely but not
completely congruent with the state level estimates. This differencemay reflect variation in
Table 1. Estimated T. cruzi cases in the United States in 2012 and confirmed cases of T. cruzi infection in donated blood per AABB from 2007–
2013, by state.
State Est. Cases AABB Cases State Est. Cases AABB Cases
Alabama 1,116 8 Montana 46 1
Alaska 110 —— Nebraska 855 3
Arizona 6,440 28 Nevada 3,712 25
Arkansas 1,161 25 New Hampshire 159 3
California 70,860 707 New Jersey 8,686 32
Colorado 3,219 4 New Mexico 1,752 4
Connecticut 1,924 8 New York 17,403 160
Delaware 339 —— North Carolina 5,408 41
D.C. 745 2 North Dakota 23 1
Florida 18,096 260 Ohio 1,142 9
Georgia 5,681 37 Oklahoma 1,407 17
Hawaii 139 —— Oregon 1,995 13
Idaho 611 —— Pennsylvania 1,804 7
Illinois 9,316 22 Rhode Island 641 1
Indiana 1,705 12 South Carolina 1,486 15
Iowa 716 5 South Dakota 82 ——
Kansas 1,273 9 Tennessee 1,900 14
Kentucky 618 9 Texas 36,977 176
Louisiana 1,427 15 Utah 1,767 24
Maine 49 1 Vermont 36 ——
Maryland 5,926 29 Virginia 7,346 103
Massachusetts 3,346 9 Washington 3,144 18
Michigan 1,258 7 West Virginia 88 1
Minnesota 1,443 2 Wisconsin 1,239 3
Mississippi 434 11 Wyoming 112 ——
Missouri 927 17 TOTAL 238,091 1,908
The AABB data included 6 confirmed infections whose state was unknown and 4 confirmed infections in Puerto Rico, not included in Table 1.
doi:10.1371/journal.pntd.0005033.t001
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community blood donation preferences related to country of origin, since blood donations are
voluntary, or possibly other cultural or social differences. [10]
There are several limitations to this study. First, we focused our estimation of the cases of
Chagas disease to documented foreign born immigrants from endemic countries in Latin
America only. Estimates of undocumented immigrants in the United States are no longer avail-
able from U.S. Department of Homeland Security, the source of population totals by country
of origin used in the previously published estimate. Recent data from the Pew Research Center
suggest that in 2012 there were approximately 11.2 million undocumented immigrants in the
United States. Moreover, among the leading countries of origin for the undocumented popula-
tion were several countries with substantial prevalence of Chagas disease,Mexico, Guatemala
and El Salvador.[11] [1]. Based on these 2012 Pew Research Center estimates of undocumented
Latin American immigrants in the United States and WHO country Chagas disease prevalence,
an additional 88,000–109,000 people with Chagas diseasemay be living in the United States,
Fig 1. Map of estimated cases of Chagas disease in the United States, 2012.
doi:10.1371/journal.pntd.0005033.g001
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bringing the estimated total number of cases to between 326,000 and 347,000. Because of gaps
in data available, we cannot provide state level estimates of Chagas disease among undocu-
mented Latin American immigrants. A second limitation of this study was the inability to
obtain reliable data to estimate both autochthonous of T. cruzi transmission and congenital
transmission of T. cruzi infection among populations of Latin American origin. A third limita-
tion of this study was that we assumed the prevalence of Chagas disease in the foreign born US
immigrant population was equal to that of the country of origin. Due to a lack of data, we were
unable to account for age, sex or year of immigration. Finally, for states whose population in
any of the Hispanic origin groups was too small to be estimated, they were assumed to have
zero members in that group and consequently no expected infections. If anything, this would
result in an underestimation of the true number of cases.
These findings have important implications for health policy regarding Chagas disease in
the US. The estimate from this study is similar to the previous report and suggests a continuing
burden of Chagas disease in the US. This research is a critical first step in addressing Chagas
disease in the United States. Other important research gaps in our understanding of the epide-
miology of this disease in the US include: (1) representative studies to generate an evidence-
based prevalence of disease nationwide; (2) studies to estimate the risk for acquiring T. cruzi
infection via congenital or autochthonous transmission in the US; and (3) a national level defi-
nition of the contribution of T. cruzi infections to cardiac disease. Defining the Chagas disease
burden in the US is necessary to inform efforts to ensure access to appropriate care and treat-
ment among the populations at risk.
In conclusion, this study demonstrates a sustained substantial burden of Chagas disease in
the US and offers the first state level prevalence estimates for Chagas disease.We also show
state variation in burden, reflecting the distribution of at risk Latin American immigrant popu-
lations. The study lends important new insight into the distribution of this disease in the US
and highlights the need for further research quantifying prevalence and incidence to guide
interventions for control of Chagas disease across the US.
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